首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
【24h】

Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.

机译:比较两端口和四端口照射在局部浸润性膀胱癌的膀胱保存治疗中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To ascertain therapeutic effectiveness and adverse reactions with radiochemotherapy for locally invasive bladder cancer, comparison was made between two-port and four-port irradiation with intravenous cisplatin administration. METHODS: In 86 patients who were diagnosed with locally invasive bladder cancer on the basis of imaging and biopsy findings, transurethral tumor resection was carried out initially to minimize tumor volume, and then radiochemotherapy was done. From 1985 to 1997, bilateral two-port irradiation was carried out, and after 1998, four-port irradiation was done. In regards to chemotherapy, cisplatin was administered intravenously. Therapeutic effects were assessed 1 month after the end of therapy. RESULTS: Fifty-five patients underwent two-port irradiation; complete response (CR) was achieved in 26 and partial response (PR) in 29 patients. Thirty-one patients underwent four-port irradiation; CR was achieved in 20 patients and PR in 11 patients. The cause-specific 5-year survival rate did not differ significantly between two-port and four-port irradiation (74%vs 79%), but there was a significant difference of survival between CR and PR patients. In the two-port irradiation group, 5-year bladder preservation rate was 89% in CR patients and 52% in PR patients. In the four-port irradiation group, 5-year bladder preservation rate was 90% in CR patients and 46% in PR patients. Of the various adverse reactions, no significant differences in leukopenia, thrombocytopenia or bladder symptoms were observed between two-port and four-port irradiation, but the incidence and severity of loss of appetite, nausea and/or vomiting, diarrhea and dermatitis were significantly greater for two-port irradiation. CONCLUSION: Radiochemotherapy are considered to be modest effective in the bladder preservation therapy for locally invasive bladder cancer. The four-port irradiation shows less adverse reactions than two-port irradiation.
机译:目的:为了确定放化疗对局部浸润性膀胱癌的治疗效果和不良反应,比较了顺铂静脉注射的两端口和四端口照射之间的差异。方法:根据影像学和活检结果诊断出的86例局部浸润性膀胱癌患者中,首先行经尿道肿瘤切除术以最小化肿瘤体积,然后进行放化疗。 1985年至1997年,进行了双边两端口照射,1998年之后,进行了四端口照射。关于化学疗法,顺铂是静脉内给药。治疗结束后1个月评估治疗效果。结果:55例患者接受了两端口放射治疗。 26例患者获得完全缓解(CR),29例患者获得部分缓解(PR)。 31例患者接受了四端口放射治疗。 CR达到20例,PR达到11例。两端口和四端口照射的病因特异性5年生存率没有显着差异(74%vs 79%),但是CR和PR患者的存活率存在显着差异。在两端口照射组中,CR患者的5年膀胱保存率分别为89%和PR患者的52%。在四端口照射组中,CR患者的5年膀胱保存率分别为90%和PR患者的46%。在各种不良反应中,两口和四口照射之间的白细胞减少症,血小板减少症或膀胱症状没有显着差异,但是食欲不振,恶心和/或呕吐,腹泻和皮炎的发生率和严重程度明显更高。用于两端口照射。结论:放疗在局部浸润性膀胱癌的膀胱保存治疗中被认为是适度有效的。四端口辐射显示出比两端口辐射更少的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号